Impact of non-alcoholic fatty liver disease on coronary artery disease: a mendelian randomization study
Low production of 12_-hydroxylated bile acids prevents hepatic steatosis in mice with a human-like bile acid pool by reducing fat absorption
De novo lipogenesis mediates beneficial effects of isoenergetic dietary interventions on fatty liver: insights from the medea randomized clinical trial
High antibody titers against apolipoprotein-A1 in NAFLD: a possible link between fatty liver disease and CVD?
Non-alcoholic steatohepatitis is reflected by levels of systemic soluble TREM2 and limited by the recruitment of TREM2-positive macrophages to areas of lipid-induced tissue damage
